LWM
IDXX icon

LeConte Wealth Management’s Idexx Laboratories IDXX Stock Holding History

LeConte Wealth Management’s Portfolio IDXX Stock Details IDXX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$245K Sell
466
-21
-4% -$11.8K 0.13% 127
2026
Q1 		$274K Buy
487
+37
+8% +$23.7K 0.18% 102
2025
Q4 		$304K Buy
450
+75
+20% +$51.1K 0.2% 82
2025
Q3 		$240K Buy
+375
New +$228K 0.16% 103

Other funds holding IDXX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return

LeConte Wealth Management's IDXX Position: Q2 2026 in Review

LeConte Wealth Management reduced its Idexx Laboratories (IDXX) stake by 4.3% in Q2 2026, selling an estimated $11.8K and leaving 466 shares worth $245K. The position accounts for 0.13% of the portfolio, ranked #127.

LeConte Wealth Management first reported a position in IDXX in Q3 2025 and has held it in 4 quarters since. The position peaked at $304K in Q4 2025. 1,302 funds tracked by Wall St. Rank hold IDXX as of Q2 2026.

  • LeConte Wealth Management held 466 shares of Idexx Laboratories worth $245K as of Q2 2026.
  • LeConte Wealth Management sold 21 Idexx Laboratories shares in Q2 2026, an estimated $11.8K.
  • Idexx Laboratories made up 0.13% of LeConte Wealth Management's portfolio in Q2 2026, its #127 holding.
  • LeConte Wealth Management first reported a position in Idexx Laboratories in Q3 2025 and has held it in 4 quarters since.
  • LeConte Wealth Management's Idexx Laboratories position peaked at $304K in Q4 2025.
  • 1,302 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2026.

Based on LeConte Wealth Management's 13F filing for Q2 2026, filed 7 Aug 2026.